Neuroscience reveals how social rewards and relational value drive human connection

Though painful, social rejection can be a powerful learning tool, new USC research suggests.

Numinus Applies for Management Cease Trade Order | Psychedelic Invest

VANCOUVER, BC, Nov. 15, 2024 /PRNewswire/ – Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (“Numinus” or the “Company“), a leader in mental health care specializing in innovative and evidence-based treatments, announces

November 18, 2024

Silence Therapeutics Plc Patent: Compound for Liver Disease RNA Therapy

Share this article According to GlobalData’s company profile on Silence Therapeutics, was a key innovation area identified from patents. Silence Therapeutics‘s grant share as of

April 22, 2024

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.